Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Impact Biomedical Inc. (IBO:NYSE), powered by AI.
Impact Biomedical Inc. is currently trading at $0.55. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Impact Biomedical Inc. on Alpha Lenz.
View Impact Biomedical Inc.'s valuation metrics on Alpha Lenz.
“Impact Biomedical Inc.'s ROE is -140.4%. Explore profitability and growth together.”
Ask for details →Impact Biomedical Inc. is a pioneering company within the biotechnology sector, focused on developing innovative solutions that address key challenges in health and wellness. The primary function of Impact Biomedical Inc. is to research and create cutting-edge biotechnologies that have the potential to significantly impact pharmaceuticals, cosmetics, and other health-related industries. Notable features of the company include its strong emphasis on developing anti-pathogenic compounds, next-generation health supplements, and immunotherapy treatments. Impact Biomedical collaborates with research institutions and global partners to leverage scientific advancements and bring novel products to the market. As a player in the biotech market, Impact Biomedical Inc. plays a crucial role in advancing medical science and providing tools that combat health threats, contributing to the overall development and enhancement of public health solutions. Its innovations are particularly significant as they promise improvements in treatment efficacy and accessibility, thereby influencing various sectors aligned with health and disease prevention.
“Impact Biomedical Inc.'s ROE is -140.4%. Explore profitability and growth together.”
Ask for details →Impact Biomedical Inc. (ticker: IBO) is a company listed on NYSE in the Healthcare sector (Biotechnology). It has approximately 2 employees.
The current price is $0.546 with a P/E ratio of -x and P/B of -x.
ROE is -140.36% and operating margin is -13343.75%. Annual revenue is $32,000.